In the BioHarmony Drug Report Database
Mirvetuximab soravtansine
Mirvetuximab soravtansine is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Trade Name
|
|
|---|---|
Common Name
|
mirvetuximab soravtansine |
ChEMBL ID
|
CHEMBL3545132 |
Indication
|
|
Drug Class
|
Monoclonal antibodies: chimeric, tumors as target; maytansinoid derivatives |
Image (chem structure or protein)
